XELOX Chemotherapy

DRUG3 trials

Sponsors

Zhejiang University, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Chongqing University Cancer Hospital

Conditions

Advanced HCCAdverse Drug EventChemotherapyComplicationsEfficacy and SafetyHospital CostsImmunotherapyLength of Stay

Phase 2

A Prospective, Multicenter, Single-Arm Phase II Exploratory Study of Serplulimab Combined With Oncolytic Virus H101, Short-Course Radiotherapy, and XELOX Chemotherapy as Total Neoadjuvant Treatment for Locally Advanced (cT1-3N0M0) Rectal Cancer

Not yet recruitingNCT07543848

Chongqing University Cancer HospitalRectal Adenocarcinoma, Rectal Neoplasms

Start: 2026-05-01End: 2028-12-31Target: 20Updated: 2026-04-22

Phase 3

Study Comparing Conventional and Fast Track Multi-Discipline Treatment Interventions for Colorectal Cancer

CompletedNCT01080547

Zhejiang UniversityAdverse Drug Event, Complications, Hospital Costs +2

Start: 2010-03-31End: 2014-12-31Updated: 2017-04-06

Unknown Phase

Efficacy of Target - Immunotherapy and XELOX Chemotherapy for Advanced HCC

CompletedNCT06818097

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAdvanced HCC, Chemotherapy, Efficacy and Safety +3

Start: 2021-10-01End: 2025-04-01Updated: 2025-05-20

Related Papers

Fast-track multidisciplinary treatment versus conventional treatment for colorectal cancer: a multicenter, open-label randomized controlled study

BMC Cancer2019-10-238 citations

Fast track multidiscipline treatment versus conventional treatment for colorectal cancer: The results of a prospective randomized controlled study (FTMDT trial).

Journal of Clinical Oncology2017-02-01

Laparoscopic surgery contributes more to nutritional and immunologic recovery than fast-track care in colorectal cancer

World Journal of Surgical Oncology2015-02-0327 citations

Fast track multi-discipline treatment (FTMDT trial) versus conventional treatment in colorectal cancer--the design of a prospective randomized controlled study.

2011-11-245 citations